Market Overview

UPDATE: Goldman Sachs Upgrades Bruker Corporation to Buy on Operational Improvements

Share:
Related BRKR
Wall Street's M&A Chatter From September 26: Siemens-Alstom, Trivago-Tripl, Bruker-Merlin
Benzinga's Top Upgrades, Downgrades For July 13, 2017

Goldman Sachs raised its rating on Bruker Corporation (NASDAQ: BRKR) from Neutral to Buy and raised its price target from $13 to $19.

Goldman Sachs commented, "We upgrade shares of Bruker (BRKR) to Buy from Neutral and raise our 12-month price target to $19 (from $13), which implies 40% upside. After underperforming Tools peers by 1000bp YTD, we see a turnaround story for 2013 with healthy organic growth, margin expansion, and an attractive risk/reward profile coupled with the following catalysts: (1) better-than-expected strength in core end markets, (2) pending detail on long-term margin expansion plans, and (3) low expectations/valuation that sets up a “laggards to leader” trade."

Bruker Corporation closed at $13.61 on Friday.

Latest Ratings for BRKR

DateFirmActionFromTo
Jul 2017Wells FargoDowngradesMarket PerformUnderperform
Jan 2017Deutsche BankInitiates Coverage OnHold
Jan 2017BarclaysDowngradesOverweightEqual-Weight

View More Analyst Ratings for BRKR
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (BRKR)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...